Oligonucleotide performance depends on more than the nominal sequence. Truncated synthesis products, incomplete deprotection, salts, small-molecule reagents, aggregates, and modification-related side products can affect hybridization, enzymatic reactions, conjugation, or quantitative assays. Our oligo analysis and purification services help research teams characterize customer-supplied or newly synthesized DNA, RNA, and modified oligonucleotides and select a purification method that matches the molecule and downstream workflow.
The service combines analytical separation, mass-based identity checks, electrophoretic assessment, concentration measurements, and purification methods such as reverse-phase HPLC, ion-exchange chromatography, PAGE, desalting, and selected size-based cleanup. Method selection is guided by oligo length, sequence, charge, hydrophobicity, modification pattern, quantity, target purity, and intended application. Related synthesis projects can be coordinated with custom oligo synthesis and oligo modification services.
Truncated Sequences: Stepwise synthesis generates shorter failure sequences when coupling is incomplete. Their similarity to the full-length oligo can make them difficult to remove, especially as sequence length increases.
Modification-Driven Heterogeneity: Fluorophores, lipids, linkers, phosphorothioates, modified bases, or other functional groups can alter charge and hydrophobicity. The purification method must exploit a separation mechanism that still distinguishes the desired product from related species.
Salt and Reagent Carryover: Desalting can remove small ionic and organic components but does not necessarily resolve n−1 or closely related oligonucleotide impurities. Projects must distinguish between cleanup and true sequence-level purification.
Long Oligo Resolution: As oligonucleotide length increases, differences between full-length and truncated species become proportionally smaller. PAGE, ion-exchange, or optimized chromatography may be more informative than simple desalting.
Purity vs. Recovery: More aggressive purification can improve separation while reducing recovered material. The target specification should balance analytical need, available starting quantity, modification cost, and downstream sensitivity.
Method-Specific Bias: A single method may not adequately characterize identity, purity, and concentration. Orthogonal techniques such as chromatography plus MS or CE can provide more complete information for complex oligos.
Our workflow begins by defining what must be removed or measured. A short unmodified primer, a long RNA oligo, a dual-labeled probe, and a highly charged modified oligo require different separation and analytical strategies.
When a project includes labels or complex functional groups, purification can be planned together with oligo labeling modifications and post-purification verification.
Purification method should be selected according to the impurity profile and molecular properties, not by oligo length alone. For a focused comparison, see our guide to HPLC versus PAGE oligonucleotide purification.
| Purification Method | Separation Basis | Best Fit | Strengths | Key Considerations |
| Desalting / SPE | Differential retention of oligo versus small molecules | Routine cleanup after synthesis or reaction workup | Efficient removal of salts and low-molecular-weight reagents | Does not reliably remove n−1 or closely related sequence impurities |
| RP-HPLC / Ion-Pair HPLC | Hydrophobic interaction, often enhanced by ion pairing | Unmodified oligos and many labeled or hydrophobic modified oligos | Scalable, fraction-based, compatible with analytical reinjection | Retention may be dominated by hydrophobic tags; mobile-phase removal may be needed |
| Ion-Exchange HPLC | Charge-based retention | Longer or highly charged DNA/RNA and selected modified oligos | Strong separation by charge/length differences and useful orthogonal selectivity | Method depends on pH, salt gradient, backbone chemistry, and column chemistry |
| Denaturing PAGE | Electrophoretic mobility by size/charge | Long oligos and products requiring sharp discrimination from shorter fragments | Can resolve full-length material from closely related truncation products | Recovery and throughput may be lower than chromatography; post-extraction cleanup is required |
| Size-Exclusion / Gel Filtration | Hydrodynamic size | Removal of salts, aggregates, or large/small molecular contaminants | Mild separation with minimal interaction with the oligo | Limited resolution between oligos of similar size; often used as cleanup rather than final sequence purification |
Orthogonal analysis improves confidence because each method probes a different property of the oligonucleotide.
| Analytical Method | Primary Measurement | Useful For | Typical Output | Important Limitation |
| Analytical HPLC/UPLC | Chromatographic purity and impurity profile | Routine purity assessment, modified oligos, method development | Chromatogram, relative peak areas, retention profile | Coelution can hide chemically similar species |
| Ion-Exchange HPLC | Charge/length-related heterogeneity | Long oligos, phosphorothioate-rich or highly charged constructs | Chromatogram and impurity pattern | Requires chemistry-specific conditions and may not identify each peak |
| Capillary Electrophoresis | Electrophoretic size/charge distribution | Long oligos, purity assessment, closely related length variants | Electropherogram and relative component distribution | Mobility can be affected by structure and modification chemistry |
| Mass Spectrometry | Molecular mass | Identity confirmation and major mass-shift detection | Observed mass and comparison with expected product | Isomeric or positional changes may not be distinguished by intact mass alone |
| UV-Vis | Absorbance and concentration estimate | Routine concentration, dye-containing oligos, sample normalization | Concentration and absorbance profile | Does not establish sequence identity or resolve individual impurities |
| Denaturing PAGE | Size-related purity profile | Long DNA/RNA, degradation or truncation assessment | Gel image and target-band assessment | Primarily qualitative/semiquantitative unless paired with other analysis |
The workflow separates initial characterization from method selection so purification is based on the actual molecule and impurity pattern.
Collect sequence, length, backbone chemistry, labels or conjugates, sample amount, current purity information, target specification, and downstream application.
Use available analytical information or perform an initial HPLC, CE, PAGE, UV, or MS assessment to identify major product and impurity features.
Choose the purification mechanism—desalting, reverse phase, ion exchange, PAGE, or another fit-for-purpose approach—and optimize conditions for resolution and recovery.
Process the oligonucleotide, collect target fraction(s), and remove solvent, salts, or gel-extraction components as appropriate.
Reanalyze purified material using the primary method and, when needed, an orthogonal technique to confirm identity and purity.
Prepare the oligo in the agreed form and provide analytical traces, mass data, concentration information, or method notes defined in the project scope.
Choosing the right method can improve both usable recovery and confidence in the material. Our approach emphasizes molecule-specific method selection and orthogonal verification when needed.
Purification and analytical verification are especially important when low-level impurities, concentration errors, or heterogeneous products can affect assay interpretation.
Provide the oligonucleotide sequence, chemistry, modifications, amount, current analytical information, target purity, and downstream application. We will recommend a characterization and purification route based on the molecule rather than a default method. Projects can also connect with custom oligo synthesis, oligo modification services, and oligo labeling modifications. Contact us to discuss your oligo quality requirements.
HPLC is often effective for many unmodified and modified oligos, while denaturing PAGE can provide useful size discrimination for longer oligos and closely related truncation products. Sequence, length, modifications, quantity, and recovery needs should be considered together.
Desalting primarily removes salts and small-molecule reagents. It generally does not provide the resolution needed to remove n−1 or other closely related sequence impurities.
A common approach combines chromatographic or electrophoretic purity assessment with mass spectrometry for molecular-mass confirmation. UV measurement can be added for concentration, and orthogonal methods can be used for complex products.
Yes, but the method may need to be adjusted because fluorophores, lipids, linkers, charged groups, or backbone modifications can change chromatographic retention and electrophoretic mobility.
Yes. Customer-supplied material can be reviewed for sequence, chemistry, available amount, current purity information, target specification, and downstream use before the analytical or purification workflow is selected.
Loading ......
